Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 8/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 7/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 5/20 | 0.36 |
| ▸ | LMNA | P02545 | 5/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.36 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 5/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.36 |
| ▸ | USP2 | O75604 | 2/20 | 0.36 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.36 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21710487 | 0.89 | CA1 (0.39) | CA1CA2ADORA2ACYP1A2CYP3A4 | |
| SCHEMBL21710708 | 0.88 | CA1 (0.40) | CA1CA2ENPP3PGRMEN1 | |
| SCHEMBL22679444 | 0.88 | PDPK1 (0.33) | ADORA2ACYP1A2CYP3A4CYP2D6LMNA | |
| SCHEMBL22679437 | 0.88 | MAP4K4 (0.42) | ADORA2ACYP1A2CYP3A4CYP2D6LMNA | |
| SCHEMBL22679280 | 0.86 | CA1 (0.41) | CA1CA2CYP1A2CYP3A4LMNA | |
| SCHEMBL21710477 | 0.85 | PTGES (0.34) | CYP1A2LMNATSHRALDH1A1MEN1 | |
| SCHEMBL22679274 | 0.85 | ENPP3 (0.39) | CA1CA2ADORA2ACYP1A2CYP3A4 | |
| SCHEMBL21710465 | 0.84 | ENPP3 (0.40) | ADORA2ACYP1A2CYP3A4CYP2D6LMNA | |
| SCHEMBL21710705 | 0.84 | PTGES (0.36) | CYP1A2TSHRALDH1A1MEN1KMT2A | |
| SCHEMBL21717347 | 0.82 | MAP4K4 (0.43) | ADORA2ACYP1A2CYP3A4CYP2D6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11723272-B2 | Organic electroluminescence element and electronic device | IDEMITSU KOSAN CO., LTD. (JP) | 2023-08-08 | — | — | US | disclosed |
| US-20210005825-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2021-01-07 | — | — | US | disclosed |
| US-20210005826-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS | IDEMITSU KOSAN CO., LTD. (JP) | 2021-01-07 | — | — | US | disclosed |
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200052225-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE | LEF1, L1CAM, ESR2 | CA1 2666/4885CA2 1903/4885ADORA2A 4512/4885 |
| US-20210005825-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE | OR51E2, CD99, CTNND1 | CA1 2333/4885CA2 2351/4885ADORA2A 3109/4885 |
| US-20210005826-A1 | ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC APPARATUS | EML4, EBPL, LEF1 | CA1 2980/4885CA2 3016/4885ADORA2A 3275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.